Healthcare Sales & Marketing Network News: tachycardia

Searching News Database: tachycardia

HSMN NewsFeed - 7 Jul 2026
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
Devices Cardiology

HSMN NewsFeed - 17 Apr 2026
Corify Care Receives FDA Clearance for ACORYS(R) -- Introducing Instant, 4-D Electroanatomical Cardiac Mapping in Real-time
Devices Cardiology FDA

HSMN NewsFeed - 13 Apr 2026
Lilly's Jaypirca (Pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Nov 2025
Volta Medical Brings Volta AF-Xplorer(TM) II to the U.S., Ushering in a New Era of AI in Ablation for Complex Atrial Fibrillation
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 28 Jun 2024
AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY(R)) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 14 Jun 2024
TALVEY(R) (talquetamab-tgvs) Demonstrates Highly Durable, Longer-Term Responses in Patients with Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Oct 2023
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
Devices Cardiology FDA

HSMN NewsFeed - 6 Oct 2023
Amgen Completes Acquisition of Horizon Therapeutics plc
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 18 Sep 2023
Field Medical, Inc. Announces Oversubscribed Seed Round to Advance Next-Generation Cardiac Ablation Technology
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Devices Cardiology Regulatory

HSMN NewsFeed - 22 Dec 2022
ITC Rules Apple Violated AliveCor's Patents
Devices Cardiology Litigation

HSMN NewsFeed - 17 Oct 2022
Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Aug 2022
Medtronic completes acquisition of Affera
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 1 Feb 2022
FDA Clears World's First Credit-Card-Sized Personal ECG
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 13 Jan 2022
PANTHERx Rare(R) Selected by Xeris Pharmaceuticals to Distribute Recorlev(R) (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients with Cushing's Syndrome
Biopharmaceuticals Distribution

HSMN NewsFeed - 11 Jan 2022
AliveCor Announces Strategic Additions to Executive Team
Devices Monitoring Personnel

HSMN NewsFeed - 7 Jan 2022
NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
Devices Monitoring Cardiology

HSMN NewsFeed - 21 Jul 2021
Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older
Biopharmaceutical Neurology Product Launch

HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 26 May 2021
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Devices Cardiology FDA

HSMN NewsFeed - 17 May 2021
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 16 Apr 2021
Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Feb 2021
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
Biopharmaceuticals

HSMN NewsFeed - 23 Nov 2020
FDA Clears First of its Kind Algorithm Suite for Personal ECG
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 6 Oct 2020
REYVOW(R) (lasmiditan) C-V Demonstrated Superior Pain Freedom At 2 Hours in At Least 2 of 3 Migraine Attacks in New Phase 3 Consistency of Effect Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Sep 2020
REYVOW(TM) (lasmiditan) C-V Demonstrated Pain Freedom from Migraine Attacks At 60 Minutes and Up to 48 Hours in New Phase 3 Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Jul 2020
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options
Biopharmaceuticals Drug Delivery Regulatory

HSMN NewsFeed - 30 Jun 2020
ANI Pharmaceuticals Announces Launch of Mexiletine Hydrochloride Capsules
Biopharmaceuticals Cardiology Generics Product Launch

HSMN NewsFeed - 29 Jun 2020
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx(TM) Insertable Cardiac Monitor System
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 18 Dec 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 31 Oct 2019
Baylis Medical Introduces a 2-French Electrophysiology Catheter into North America
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 10 Sep 2019
Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 25 Jul 2019
U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Jun 2019
Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 13 May 2019
FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 9 May 2019
Varian Acquires CyberHeart
Devices Oncology Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2019
FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 16 Apr 2019
Milestone Pharmaceuticals Appoints Paul Edick Chairman of its Board of Directors
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 9 Apr 2019
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA(R) and INVEGA SUSTENNA(R) for the Treatment of Schizophrenia
Biopharmaceuticals

HSMN NewsFeed - 1 Apr 2019
Audentes Therapeutics Appoints Legal and Corporate Communications Executives; Promotes Thomas P. Soloway to Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Nov 2018
Audentes Therapeutics Board of Directors Appoints Co-Founder and Chief Executive Officer Matthew R. Patterson as Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Sep 2018
Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc(R) Injection in Single-Dose Bags
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 21 Aug 2018
Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regenerative Medicine FDA

HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jun 2018
Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 May 2018
ADAPT Pharma(R) Launches NARCANDirect.com
Biopharmaceuticals Product Launch

HSMN NewsFeed - 17 May 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess(R) in China
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Apr 2018
Cardiome Completes Enrollment in the Post Approval Safety Study SPECTRUM Evaluating Brinavess(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals

HSMN NewsFeed - 13 Feb 2018
Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Biopharmaceuticals Generics FDA Product Launch

HSMN NewsFeed - 1 Feb 2018
Partner Therapeutics (PTx) Acquires Leukine(R) from Sanofi
Biopharmaceuticals Oncology Acquisitions

HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA

HSMN NewsFeed - 13 Dec 2017
Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital

HSMN NewsFeed - 21 Nov 2017
Audentes Therapeutics Announces Publication of Data from RECENSUS, a Retrospective Medical Record Review of Patients With X-Linked Myotubular Myopathy
Biopharmaceuticals

HSMN NewsFeed - 22 Sep 2017
Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD
Devices Cardiology FDA

HSMN NewsFeed - 11 Sep 2017
electroCore Announces Results from gammaCore(R) (non-invasive vagus nerve stimulator) Study in Migraine at the 18th Congress of the International Headache Society
Devices Neurology

HSMN NewsFeed - 21 Aug 2017
Cardiome Provides U.S. Regulatory Update For BRINAVESS
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 18 Jul 2017
Audentes Therapeutics Announces Appointment of Fulvio Mavilio, Ph.D. to Vice President Scientific Affairs, Europe
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Jul 2017
CathVision Raises Venture Funding to Market New EP Recording System
Devices Cardiology Venture Capital

HSMN NewsFeed - 13 Jun 2017
Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jun 2017
Cardiome Announces Commercial Launch of BRINAVESS(R) (Vernakalant Hydrochloride) in Canada
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 28 Apr 2017
FDA Approves Radius Health’s TYMLOS(TM) (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2017
BIOTRONIK Introduces Smallest MR Conditional Defibrillator Lead in the US
Devices Cardiology Radiology Product Launch

HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA

HSMN NewsFeed - 7 Mar 2017
Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 13 Jan 2017
Abbott Announces U.S. Launch and First Commercial Use of the New EnSite(TM) Precision Cardiac Mapping System
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 5 Oct 2016
St. Jude Medical Announces European Full Market Release of EnSite Precision Cardiac Mapping System
Devices Cardiology Product Launch

HSMN NewsFeed - 31 Aug 2016
XALKORI(R) (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Jul 2016
Insys Therapeutics Announces FDA Approval of Syndros(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 May 2016
Cardiome Announces the Launch of ESMOCARD Solution for Injection in France
Biopharmaceuticals Cardiology Product Launch

HSMN NewsFeed - 19 Apr 2016
St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark
Devices Cardiology Product Launch

HSMN NewsFeed - 11 Apr 2016
Adapt Pharma Names Mike Kelly President of U.S. Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 14 Jan 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
Devices Cardiology

HSMN NewsFeed - 5 Jan 2016
Audentes Therapeutics Appoints Scott W. Morrison to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Dec 2015
Oral REVLIMID(R) Plus Dexamethasone Granted Approval for Treatment of Patients with Newly Diagnosed Multiple Myeloma in Japan
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 25 Nov 2015
Pfizer Receives European Approval to Expand Use of XALKORI(R) (crizotinib) to First-Line Treatment of Adults with ALK-Positive Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 18 Nov 2015
Pfizer Reports Positive Topline Results from Phase 3 Trial Comparing XALKORI(R) (crizotinib) to Chemotherapy in Previously Untreated East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jul 2015
Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan
Devices Cardiology

HSMN NewsFeed - 6 May 2015
EMD Serono Initiates Co-Promotion of XALKORI(R) (crizotinib) with Pfizer in the United States
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 11 Mar 2015
Mylan Launches Generic Antabuse(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 18 Dec 2014
The Medicines Company and SciClone Pharmaceuticals Establish Strategic Partnership for Two Cardiovascular Products in China
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 27 Oct 2014
St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial Fibrillation
Devices Cardiology FDA

HSMN NewsFeed - 23 Jul 2014
FDA Approves Eagle Pharmaceuticals’ Ryanodex(R) for the Treatment of Malignant Hyperthermia
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Feb 2014
Cyberonics Announces CE Mark Approval Of The AspireSR(TM) Generator For VNS Therapy(R)
Devices Regulatory

HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 2 Jan 2014
ZIO(R) Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine
Devices Cardiology Monitoring

HSMN NewsFeed - 6 Dec 2013
Sorin Group Launches Intensia Family of ICD and CRT-D Devices Featuring DF-4 High Voltage Connector
Devices Cardiology Regulatory

HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 18 Nov 2013
Late Breaking Clinical Trial Results Show Significant Delay in Atrial Fibrillation Disease Progression with Medtronic-Exclusive Pacing Features
Devices Cardiology

HSMN NewsFeed - 21 Aug 2013
Boston Scientific Receives FDA Approval For IntellaTip MiFi(TM) XP Ablation Catheter And 510(k) Clearance Of Zurpaz(TM) 8.5F Steerable Sheath
Devices Cardiology FDA

HSMN NewsFeed - 19 Aug 2013
St. Jude Medical Acquires Endosense
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 13 Aug 2013
BioVentrix Expands Use of Its Revivent(TM) System for Heart Failure Treatment with First Clinical Procedure in Germany
Devices Cardiology

HSMN NewsFeed - 18 Jul 2013
Celgene Will Discontinue Phase III ORIGIN(R) Trial in Previously Untreated Elderly Patients with B-Cell Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 May 2013
Sorin Group Announces FDA Approval and U.S. Launch of SMARTVIEW(TM) Remote Monitoring Solution for Patients with Implanted Cardiac Defibrillators
Devices Cardiology FDA Product Launch

HSMN NewsFeed - 12 May 2013
Landmark Study Demonstrates Lower Rate of Inappropriate Shocks in Patients with Sorin Dual Chamber ICD Devices
Devices Cardiology

HSMN NewsFeed - 10 May 2013
Boston Scientific Receives CE Mark Approval For The Rhythmia(TM) Mapping System
Devices Cardiology Regulatory

HSMN NewsFeed - 8 May 2013
St. Jude Medical Announces CE Mark Approval of Next-Generation Ellipse and SJM Assura High Voltage Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 30 Apr 2013
St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Devices Cardiology Regulatory Product Launch

HSMN NewsFeed - 25 Feb 2013
FDA Approves First Single-Lead ICD with Atrial Sensing
Devices Cardiology FDA

HSMN NewsFeed - 19 Nov 2012
ZYTIGA(R) Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic Castration-Resistant Prostate Cancer before Chemotherapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 31 Oct 2012
Thermedical Receives FDA 510(k) Clearance for Promising New Ablation System
Devices Oncology Cardiology FDA

HSMN NewsFeed - 11 Oct 2012
BIOTRONIK Launches Implantable BioMonitor(R) -- Highest Precision in Monitoring Arrhythmias
Devices Cardiology Monitoring

HSMN NewsFeed - 29 Jun 2012
Actelion Pharmaceuticals Announces U.S. Food and Drug Administration Approval of Supplemental New Drug Application for Second Generation VELETRI(R) (epoprostenol) for Injection
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jun 2012
Endosense and BIOTRONIK Announce CE Mark Approval, First Clinical Use of the New TactiCath(R) Quartz Force-Sensing Ablation Catheter
Devices Cardiology Regulatory

HSMN NewsFeed - 10 May 2012
FDA Approves BIOTRONIK Next Generation ICDs and CRT-Ds
Devices Cardiology FDA

HSMN NewsFeed - 10 May 2012
Biosense Webster Announces Launch of the THERMOCOOL(R) SF NAV Catheter With Curve Visualization
Devices Cardiology

HSMN NewsFeed - 9 May 2012
St. Jude Medical Announces FDA Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2012
St. Jude Medical Announces FDA Approval of Assura(TM) Implantable Defibrillators with Features that Reduce Inappropriate Shocks
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2012
BIOTRONIK Presents World's First ICD, CRT-D and CRT-P Devices With ProMRI(R) Technology at Heart Rhythm 2012
Devices Cardiology

HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Apr 2012
BIOTRONIK Evia HF-T, World's First MRI-Approved CRT Pacemaker
Devices Cardiology

HSMN NewsFeed - 16 Apr 2012
St. Jude Medical Announces CE Mark Approval of Smaller ICD with Physician-Inspired Shape
Devices Cardiology Regulatory

HSMN NewsFeed - 12 Apr 2012
New BIOTRONIK ICD and CRT-D Series Gives Patients First-Ever Access to MR Scans
Devices Cardiology

HSMN NewsFeed - 29 Mar 2012
University of Washington Medical Center 1st in Pacific Northwest to Discharge a Patient Without a Human Heart
Devices Cardiology

HSMN NewsFeed - 20 Mar 2012
Thermedical Announces Series A Financing Round
Devices Oncology Venture Capital

HSMN NewsFeed - 19 Mar 2012
Cameron Health’s S-ICD(R) System Scheduled for FDA Panel Review on April 26, 2012
Devices Cardiology FDA

HSMN NewsFeed - 12 Jan 2012
Endosense Launches TactiCath(R) 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study
Devices Cardiology

HSMN NewsFeed - 12 Jan 2012
Biosense Webster Announces FDA approval of the THERMOCOOL(R) SF Catheter in the United States
Devices Cardiology FDA

HSMN NewsFeed - 23 Nov 2011
BIOTRONIK Introduces the World’s First and Only Implantable Defibrillators Eligible for Magnetic Resonance Imaging
Devices Cardiology

HSMN NewsFeed - 14 Sep 2011
Endosense Names Jan Keltjens President and Chief Executive Officer
Devices Cardiology Personnel

HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Devices FDA

HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 24 Jun 2011
BIOTRONIK Launches Lumax 540 VR-T DX, The World’s Only Single-Chamber ICD With Complete Atrial Diagnostics
Devices Cardiology

HSMN NewsFeed - 21 Jun 2011
St. Jude Medical Announces Japanese Launch of Smaller, Higher Power ICD and CRT-D Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 5 May 2011
Endosense and BIOTRONIK Mark 1,000th Procedure Performed with the TactiCath(R) Force-Sensing Ablation Catheter
Devices Cardiology

HSMN NewsFeed - 3 May 2011
Boston Scientific Announces CE Mark Approval and First Use of Blazer Open-Irrigated Catheter in Europe
Devices Cardiology Regulatory

HSMN NewsFeed - 18 Apr 2011
Baxter Announces the Acquisition of Prism Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Apr 2011
St. Jude Medical Announces Approval of ShockGuard(TM) Technology with New DecisionTx(TM) Programming for Unify and Fortify Implantable Defibrillators
Devices Cardiology FDA

HSMN NewsFeed - 8 Mar 2011
Medtronic CareLink(R) Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs
Devices Cardiology Monitoring

HSMN NewsFeed - 31 Jan 2011
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
Devices

HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jan 2011
Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the THERMOCOOL(R) SMARTTOUCH(TM) Contact Force Sensing Catheter
Devices Cardiology

HSMN NewsFeed - 12 Jan 2011
Endosense Launches the TOCCASTAR IDE Study of Its TactiCath(R) Force-Sensing Ablation Catheter
Devices Cardiology

HSMN NewsFeed - 15 Nov 2010
St. Jude Medical Announces Results of ASSERT Study Demonstrating Effectiveness of Implantable Device Monitoring in Predicting Stroke
Devices Cardiology Monitoring Neurology

HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Sep 2010
Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Devices Monitoring Cardiology

HSMN NewsFeed - 8 Sep 2010
Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
Devices Cardiology

HSMN NewsFeed - 29 Jul 2010
Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Jul 2010
ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing

HSMN NewsFeed - 25 Jun 2010
Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 18 Jun 2010
Study: Medtronic Anatomically-Designed Catheters Reduce Lab Time Required for Pulmonary Vein Isolation by 35 Percent
Devices Cardiology

HSMN NewsFeed - 17 Jun 2010
Medtronic Announces European Launch of Protecta Portfolio with SmartShock Technology Shown to Significantly Reduce Inappropriate Shocks
Devices Cardiology

HSMN NewsFeed - 15 Jun 2010
Endosense Enrolls First Patients in ProForce, an International Post-Market Study of the TactiCath(R)
Devices Cardiology

HSMN NewsFeed - 8 Jun 2010
New ABRAXANE(R) Data Demonstrates Potential in Patients with Advanced and Malignant Melanoma, Among the Toughest Cancers to Treat
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 15 May 2010
New Medtronic Data Shows Health Care Utilization Differs by Type of Implantable Defibrillator Therapy
Devices Cardiology

HSMN NewsFeed - 13 May 2010
Endosense Announces 12-Month TOCCATA Study Data Reinforcing Clinical Benefit of the TactiCath(R)
Devices Cardiology

HSMN NewsFeed - 12 May 2010
St. Jude Medical Announces FDA Approval of Unify CRT-D and Fortify ICD
Devices Cardiology FDA

HSMN NewsFeed - 20 Apr 2010
Endosense Launches Next Generation TactiCath(R) Force-Sensing Catheter
Devices Interventional Cardiology

HSMN NewsFeed - 6 Apr 2010
Baxter and Nycomed Announce FDA Approval of TachoSil(R)
Devices Surgery FDA

HSMN NewsFeed - 18 Mar 2010
Cameron Health Commences FDA-Approved IDE Clinical Trial of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology

HSMN NewsFeed - 17 Mar 2010
ABRAXANE Meets Primary Endpoint in Phase 3 Trial for Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 5 Feb 2010
Sorin Group Announces Market Release and First Implant of Next-Generation Cardiac Resynchronization Therapy Defibrillator
Devices Cardiology

HSMN NewsFeed - 4 Feb 2010
St. Jude Medical Announces European Approval of Smaller, Higher Power ICD and CRT-D Devices with New Heart Failure Monitors
Devices Cardiology

HSMN NewsFeed - 29 Jan 2010
Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 15 Jan 2010
St. Jude Medical Announces Sponsorship of SCD-HeFT 10-Year Follow-Up Study
Devices Cardiology

HSMN NewsFeed - 14 Jan 2010
BIOTRONIK and Endosense Sign International Exclusive Distribution Partnership
Devices Cardiology Distribution

HSMN NewsFeed - 13 Jan 2010
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Jan 2010
Interim Study Data Indicate Improved Blood Pressure Management With Cardene(R) I.V. Compared to Labetalol in Patients with Acute Stoke
Biopharmaceuticals Cardiology Neurology

HSMN NewsFeed - 11 Jan 2010
Novartis Launches Schizophrenia Treatment Fanapt in the US, Offering Patients an Attractive Alternative to Existing Medications
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2010
Cardima's PATHFINDER(R) Diagnostic Catheters Receive Marketing Approval in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 10 Dec 2009
Endosense Names Jan H. Egberts, M.D. Chairman of the Board, Adds Michael J. Dormer as New Board Director
Devices Cardiology Personnel

HSMN NewsFeed - 4 Dec 2009
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Dec 2009
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Dec 2009
New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Nov 2009
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Nov 2009
Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 12 Oct 2009
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
Biopharmaceuticals Licensing

HSMN NewsFeed - 12 Oct 2009
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
Biopharmaceuticals Licensing

HSMN NewsFeed - 5 Oct 2009
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals

HSMN NewsFeed - 3 Aug 2009
Results from a Phase 2 Study of ABRAXANE(R) In Combination With Carboplatin Show Clinical Activity in the First Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 Jul 2009
St. Jude Medical Announces FDA Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology FDA

HSMN NewsFeed - 24 Jun 2009
Sorin Group Announces European Market Release and First Implant of Its New-Generation Dual Chamber Implantable Cardioverter Defibrillator
Devices Cardiology

HSMN NewsFeed - 15 Jun 2009
Cameron Health Announces CE Mark of the Minimally Invasive Totally Subcutaneous Implantable Defibrillator for Treatment of Sudden Cardiac Arrest
Devices Cardiology Regulatory

HSMN NewsFeed - 10 Jun 2009
St. Jude Medical Announces Initial Implant of First-to-Market Connector System in the U.S.
Devices Cardiology

HSMN NewsFeed - 18 May 2009
FDA Grants Approval for Use of RISPERDAL(R) CONSTA(R) as Both a Monotherapy and Adjunctive Therapy in the Maintenance Treatment of Bipolar I Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 18 May 2009
Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
Biopharmaceuticals Oncology Mergers & Acquisitions

HSMN NewsFeed - 14 May 2009
Benefits of Catheter Ablation with the NAVISTAR THERMOCOOL Catheter Sustained for One Year in the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 13 May 2009
Medtronic Launches Clinical Trial to Improve Quality of Care for Implantable Defibrillator Patients
Devices Cardiology

HSMN NewsFeed - 13 May 2009
St. Jude Medical Announces European Approval of Accent RF and Anthem RF Pacemakers Equipped With Wireless Technology
Devices Cardiology Regulatory

HSMN NewsFeed - 11 May 2009
St. Jude Medical Announces European Approval of Its Newest Heart Failure Devices Which Enable More Efficient Implantation and Follow-up
Devices Cardiology Regulatory

HSMN NewsFeed - 11 May 2009
St. Jude Medical Announces FDA Approval of Current Plus ICD and Promote Plus CRT-D Devices to Provide Therapy for Life-Threatening Arrhythmias and Heart Failure
Devices Cardiology FDA

HSMN NewsFeed - 6 May 2009
Endosense Receives CE Mark for TactiCath Force-Sensing Ablation Catheter
Devices Cardiology Regulatory

HSMN NewsFeed - 24 Apr 2009
St. Jude Medical Announces CE Mark Approval of Remote Care System for Implantable Cardiac Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 20 Apr 2009
St. Jude Medical Announces European Approval of ICDs with Features That Automatically Enhance Patient Safety and Streamline Patient Follow-up
Devices Cardiology Regulatory

HSMN NewsFeed - 13 Apr 2009
Transoma Medical Announces First Patient Enrollment in Clinical Study on Long-Term Cardiac Monitoring for Detection of Atrial Fibrillation after Cryptogenic Stroke
Devices Cardiology Monitoring

HSMN NewsFeed - 13 Apr 2009
BIOTRONIK, Inc. Announces The First U.S. Implant Of Lumax 540 Series - A Therapy For Patients Suffering From Heart Failure
Devices Cardiology

HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Mar 2009
IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 11 Feb 2009
Transoma Medical Receives FDA Marketing Clearance for Sleuth AT Implantable Cardiac Monitoring System
Devices Cardiology Monitoring

HSMN NewsFeed - 6 Feb 2009
FDA Grants Marketing Approval to NAVISTAR(R) THERMOCOOL(R) Catheter for Atrial Fibrillation
Devices Cardiology FDA

HSMN NewsFeed - 27 Jan 2009
Schering-Plough Completes Enrollment of Boceprevir Registration Studies in Treatment-Naive and Treatment-Experienced HCV Patients
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals

HSMN NewsFeed - 14 Jan 2009
St. Jude Medical Announces Japanese Approval of Atlas II ICD
Devices Cardiology Regulatory

HSMN NewsFeed - 5 Jan 2009
Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Dec 2008
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
Biopharmaceuticals

HSMN NewsFeed - 27 Nov 2008
SORIN GROUP ANNOUNCES EUROPEAN MARKET RELEASE AND FIRST IMPLANT OF NEW-GENERATION CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Devices Cardiology

HSMN NewsFeed - 18 Nov 2008
IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Europe from the Committee for Medicinal Products for Human Use (CHMP)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 11 Nov 2008
Study Finds Catheter Ablation with the NAVISTAR(R) THERMOCOOL(R) Catheter Superior to Anti-Arrhythmic Drug Therapy for the Treatment of Symptomatic, Paroxysmal Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 24 Oct 2008
Boston Scientific Announces Canadian Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology Regulatory

HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Oct 2008
Eli Lilly and Company Resolves Investigation Involving Numerous States
Biopharmaceuticals

HSMN NewsFeed - 26 Sep 2008
CHMP Recommends Approval of Olanzapine Long-acting Injection for Maintenance Treatment of Schizophrenia in Europe
Biopharmaceuticals Regulatory

HSMN NewsFeed - 26 Aug 2008
New Publication Shows Cleviprex(TM) is Safe and Effective for Treatment of Acute, Severe Hypertension
Biopharmaceuticals

HSMN NewsFeed - 6 Aug 2008
St. Jude Medical Announces Japanese Approval of the Durata Defibrillation Lead
Devices Cardiology Regulatory

HSMN NewsFeed - 4 Aug 2008
The Medicines Company's Cleviprex(TM) Receives FDA Approval
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Jul 2008
Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Jul 2008
New Publication Shows Cleviprex(TM) is Effective for Rapid Treatment of Acute Hypertension After Cardiac Surgery
Biopharmaceuticals Cardiology

HSMN NewsFeed - 24 Jun 2008
Astellas Launches Lexiscan(TM) (Regadenoson) Injection for Use as a Pharmacologic Stress Agent in Radionuclide Myocardial Perfusion Imaging (MPI)
Biopharmaceuticals Radiology Cardiology

HSMN NewsFeed - 23 Jun 2008
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
Devices Cardiology Licensing

HSMN NewsFeed - 20 Jun 2008
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Jun 2008
Vision 3D Implantable Cardiac Devices Now on Medtronic Carelink Network
Devices Cardiology

HSMN NewsFeed - 28 May 2008
Boston Scientific Completes Acquisition of CryoCor
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 19 May 2008
Bayer Announces Availability of Reformulated Liquid Leukine(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 15 May 2008
Sorin Group Announces FDA Approval of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator: OVATIO(TM) CRT
Devices Cardiology FDA

HSMN NewsFeed - 15 May 2008
Remote Monitoring of Pacemaker Patients on Medtronic Carelink(R) Network Detects Clinically Actionable Events More Quickly Than Combination of Transtelephonic Monitoring and Routine Office Visits
Devices Cardiology

HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 13 May 2008
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology FDA

HSMN NewsFeed - 13 May 2008
Medtronic Announces FDA Approval of New Vision 3D Wireless Implantable Cardiac Devices
Devices Cardiology FDA

HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology

HSMN NewsFeed - 12 May 2008
Novalar Receives FDA Approval for OraVerse(TM)
Biopharmaceuticals FDA Dental

HSMN NewsFeed - 8 May 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
Biopharmaceuticals

HSMN NewsFeed - 16 Apr 2008
Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 19 Mar 2008
Medical Device Inventor Mark W. Kroll, PhD Joins NewCardio as Chairman of the Board
Diagnostics Cardiology Personnel

HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Biopharmaceuticals

HSMN NewsFeed - 29 Feb 2008
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2008
FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Feb 2008
Spectranetics Appoints Thomas Rasmussen Vice President of Clinical Affairs
Devices Cardiology Personnel

HSMN NewsFeed - 6 Feb 2008
FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Feb 2008
Clinical Data's FAMILION Test Meets Criteria for Diagnosis of Long QT Syndrome Set By Blue Cross and Blue Shield Association Technology Evaluation Center
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 4 Feb 2008
IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 Jan 2008
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology Regulatory

HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 12 Dec 2007
Medtronic Implantable Cardiac Monitors Give Physicians Valuable Insights into Heart Rhythms
Devices Cardiology

HSMN NewsFeed - 7 Dec 2007
FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 4 Dec 2007
Sorin Group Cardiac Rhythm Management Announces the First U.S. Enrollment in the Option Study
Devices Cardiology

HSMN NewsFeed - 29 Nov 2007
Sagent Pharmaceuticals Launches Full-Line of Prefilled 6 mg and 12 mg Adenosine Syringes
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Nov 2007
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Nov 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Nov 2007
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Nov 2007
CryoCor Appoints New Vice President of Sales and Marketing
Devices Cardiology Personnel

HSMN NewsFeed - 31 Oct 2007
Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 23 Oct 2007
Cleviprex(TM) (Clevidipine Butyrate) Rapidly Reduced Blood Pressure and Maintained Control in Study of Patients with Acute Hypertension
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Oct 2007
Sorin Group Announces the First U.S. Clinical Implant of the World's Smallest Cardiac Resynchronization Implantable Cardioverter Defibrillator - OVATIO(TM) CRT
Devices Cardiology

HSMN NewsFeed - 15 Oct 2007
Improved Perioperative Blood Pressure Control Associated with Reduced Risk of Kidney Dysfunction in Cardiac Surgery Patients
Biopharmaceuticals Cardiology Surgery

HSMN NewsFeed - 5 Oct 2007
Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Biopharmaceuticals

HSMN NewsFeed - 20 Sep 2007
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Sep 2007
St. Jude Medical Announces FDA Approval of Company's First Radiofrequency Wireless ICD and CRT-D Heart Failure Devices
Devices Cardiology FDA

HSMN NewsFeed - 14 Sep 2007
FDA Accepts NDA Filing for Cleviprex(TM) (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension
Biopharmaceuticals

HSMN NewsFeed - 11 Sep 2007
Stereotaxis' Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Devices Cardiology

HSMN NewsFeed - 7 Sep 2007
Statement of Eli Lilly and Company on Dr. David Egilman Settlement
Biopharmaceuticals Litigation

HSMN NewsFeed - 31 Aug 2007
Sorin Group Launches World's Smallest Implantable Cardioverter Defibrillators in Japan
Devices Cardiology Regulatory

HSMN NewsFeed - 27 Aug 2007
IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
Devices Oncology FDA

HSMN NewsFeed - 17 Jul 2007
ABILIFY(R) (aripiprazole) Supplemental New Drug Application Receives Priority Review by U.S. Food And Drug Administration for Adjunctive Treatment in Adults With Major Depressive Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Jul 2007
Medtronic Launches First Wireless Devices in Japan
Devices Cardiology

HSMN NewsFeed - 28 Jun 2007
Boston Scientific and CryoCor Announce Strategic Collaboration in Atrial Fibrillation
Devices Cardiology

HSMN NewsFeed - 26 Jun 2007
New Patient Monitoring System Allows Routine Checkups of Deadly Heart Conditions Using the Internet
Devices Cardiology Monitoring

HSMN NewsFeed - 4 Jun 2007
ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
Biopharmaceuticals Oncology

HSMN NewsFeed - 4 Jun 2007
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2007
CARDIMA(R) Announces First Human Procedure Successfully Performed Using Standard Thorascopic Techniques With 20-Electrode Irrigated Surgical Ablation Probe
Devices Cardiology

HSMN NewsFeed - 18 May 2007
FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
Biopharmaceuticals FDA

HSMN NewsFeed - 14 May 2007
CV Therapeutics Submits New Drug Application For Regadenoson
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 May 2007
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 May 2007
St. Jude Medical Announces FDA Approvals of Current ICD and Promote CRT-D Heart Failure Devices
Devices Cardiology FDA

HSMN NewsFeed - 8 May 2007
St. Jude Medical Announces European Approval of Company's First Wireless ICD and CRT-D Heart Failure Devices
Devices Cardiology Regulatory

HSMN NewsFeed - 3 May 2007
Stereotaxis Announces European Approval of Partnered Irrigated Ablation Catheter
Devices Cardiology Regulatory

HSMN NewsFeed - 3 Apr 2007
Vicor Technologies Announces Completion of Merger; Clinical Trials for Its Sudden Cardiac Death Risk Stratification Device Continue
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 5 Mar 2007
New Study Finds Commonly Used Heart Monitoring System Often Fails to Detect Serious Cardiac Arrhythmias, a Leading Cause of Stroke and Sudden Cardiac Death
Devices Cardiology Monitoring

HSMN NewsFeed - 14 Feb 2007
Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents
Biopharmaceuticals Litigation

HSMN NewsFeed - 14 Feb 2007
Favrille Announces Agreement With Berlex, Inc. Regarding Use of FavId(R) in Combination With Leukine(R) (sargramostim) in B-Cell Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Feb 2007
FDA Approves New Dosing Recommendations for RAPAMUNE in High Immunologic Risk Renal Transplant Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jan 2007
Newly Combined Philips and Stereotaxis Technologies Improve Precise Navigation During Complex Heart Surgery
Devices Radiology Cardiology

HSMN NewsFeed - 15 Jan 2007
Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients With Type 1 Gaucher Disease
Biopharmaceuticals

HSMN NewsFeed - 15 Jan 2007
Medtronic Launches Public Awareness Campaign to Address One of the Nation's Leading Causes of Death
Devices Cardiology

HSMN NewsFeed - 10 Jan 2007
New Bi-Directional Cardiac Catheter Now Available for Treatment of Irregular Heart Rhythms
Devices Interventional

HSMN NewsFeed - 4 Jan 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Dec 2006
ABILIFY(R) (Aripiprazole) Injection for Intramuscular Use for Adults With Agitation Associated With Schizophrenia or Bipolar Mania Now Available
Biopharmaceuticals

HSMN NewsFeed - 12 Dec 2006
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
Biopharmaceuticals

HSMN NewsFeed - 7 Dec 2006
ABILIFY(R) (aripiprazole) Demonstrated Efficacy as Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Following Treatment for a Recent Manic Or Mixed Episode
Biopharmaceuticals

HSMN NewsFeed - 4 Dec 2006
Largest Prospective Study of Microvolt T-Wave Alternans Demonstrates This Technology's Predictive Value for Sudden Cardiac Death in Patients With Preserved Left Ventricular Function After Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 4 Dec 2006
Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Nov 2006
Vicor Technologies Initiates Clinical Sites for Pivotal Vital Trial; Enrolls First Two Patients; Targets FDA 510(k) Submission in 2008
Devices Monitoring Cardiology

HSMN NewsFeed - 27 Nov 2006
Genzyme Begins Phase 2 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Nov 2006
Sorin Group Initiates Multi-Center 'OPTION' Study in Europe
Devices Cardiology

HSMN NewsFeed - 13 Nov 2006
WellPoint To Cover Microvolt T-Wave Alternans Testing
Devices Cardiology Reimbursement

HSMN NewsFeed - 9 Nov 2006
Study in Today's New England Journal of Medicine Shows Benefits of Thymoglobulin Use
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2006
IDM Pharma Submits Filing for European Market Approval of Mepact(TM) (mifamurtide, Junovan(TM) in the US) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 7 Nov 2006
St. Jude Medical Announces FDA Approval of New ICD Software for the Merlin(TM) Patient Care System
Devices Cardiology FDA

HSMN NewsFeed - 6 Nov 2006
Cytokinetics Announces Presentations Relating to Clinical Trial Data on CK-1827452 and its Cardiac Myosin Activator Program at the 2006 Annual American Heart Association Scientific Sessions Meeting
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Nov 2006
Arizona Arrhythmia Consultants Seeks Heart Failure Patients For Investigational Study Evaluating Use of New Implantable Pulse Generator
Devices Cardiology

HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2006
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 23 Oct 2006
Data for XOPENEX(R) Brand of Levalbuterol Presented at American College of Chest Physicians Annual Conference
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2006
Stonebridge Pharma and Capellon Pharmaceuticals Announce Co-Promotion Agreement to Market Symax(TM) Duotab (hyoscyamine sulfate) for Irritable Bowel Syndrome
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Oct 2006
Sorin Group Expands Its Presence in the Japanese Market by Introducing Advanced Defibrillation Therapy
Devices Cardiology

HSMN NewsFeed - 27 Sep 2006
Mortara Instrument, Inc. Announces eCardio Diagnostics as the First Service Provider Offering the New H3+ Holter Monitor for Arrhythmia Assessment
Devices Monitoring Cardiology

HSMN NewsFeed - 6 Sep 2006
OVATION and Cardinal Health Announce FDA Approval Letter for Manufacturing of Biologic Therapy To Treat Rare Genetic Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Sep 2006
Genzyme Begins Phase 3 Pivotal Study of Clolar(R) in Adult Acute Myelogenous Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jul 2006
FDA Grants Review of Issues Pertaining to Cardima's REVELATION(R) Tx PMA
Devices Cardiology FDA

HSMN NewsFeed - 18 Jul 2006
St. Jude Medical Announces FDA Approval of Atlas II ICD and Atlas II Heart Failure Devices
Devices Cardiology FDA

HSMN NewsFeed - 25 May 2006
Cardima Receives FDA Market Clearance for New Surgical Ablation System
Devices Cardiology Surgery FDA

HSMN NewsFeed - 24 May 2006
UCB Completes Mutual Recognition Procedure for Equasym(TM) XL
Biopharmaceuticals Regulatory

HSMN NewsFeed - 23 May 2006
New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 16 May 2006
St. Jude Medical Announces FDA Approval of Epic II ICD and Epic II Heart Failure Devices
Devices Cardiology FDA

HSMN NewsFeed - 16 May 2006
Sorin Group Announces FDA Approval of World's Smallest Implantable Cardioverter Defibrillator; OVATIO(TM) Offers Advanced Pacing and Defibrillation Technology to Patients at Risk for Sudden Cardiac Arrest
Devices Cardiology FDA

Return to NewsFeed

Additional items found! 129

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 129 additional stories matching:
tachycardia
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!